{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:11:51Z","timestamp":1792541511909,"version":"4.5.0"},"reference-count":49,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"unspecified","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000098","name":"NIH Clinical Center","doi-asserted-by":"publisher","award":["K24HL160527"],"award-info":[{"award-number":["K24HL160527"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2023,9,6]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To investigate the association of medication copayment and treatment adherence to hydroxychloroquine and immunosuppressants for SLE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a retrospective analysis of health claims data using Optum\u2019s de-identified Clinformatics Data Mart Database. Individuals with SLE continuously enrolled for 180 days from 1 July 2010 to 31 December 2019 were included. Adherence was defined as the proportion of days covered \u226580%. Copayment for a 30-day supply of medication was dichotomised as high (\u2265$10) or low (&lt;$10). We examined the association between copayment and odds of adherence in multivariable-adjusted logistic regression models, including age, sex, race or ethnicity, comorbidities, educational attainment and household income.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 12 510 individuals (age 54.2\u00b115.5 years; 88.2% female sex), of whom 9510 (76%) were prescribed hydroxychloroquine and 1880 (15%) prescribed hydroxychloroquine and an additional immunosuppressant (azathioprine, methotrexate or mycophenolate mofetil). Median (IQR) 30-day copayments were $8 (4\u201310) for hydroxychloroquine, $7 (2\u201310) for azathioprine, $8 (3\u201311) for methotrexate and $10 (5\u201320) for mycophenolate mofetil. High copayments were associated with OR of adherence of 0.61 (95% CI 0.55 to 0.68) for hydroxychloroquine, OR 0.44 (95% CI 0.30 to 0.66) for azathioprine and OR 0.69 (95% CI 0.49 to 0.96) for mycophenolate mofetil. For methotrexate, the association was not significant.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In a large, administrative health claims database, we identified that high copayments were associated with reduced adherence to commonly prescribed medications for SLE. Incorporating awareness of the burden of copayments and its consequences into healthcare is essential to promote optimal medication adherence.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/lupus-2023-000966","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T13:11:47Z","timestamp":1697634707000},"page":"e000966","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Association of patient copayment and medication adherence in systemic lupus erythematosus"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2830-7675","authenticated-orcid":false,"given":"Raisa","family":"Lomanto Silva","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen M","family":"Swabe","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3945-6828","authenticated-orcid":false,"given":"Sebastian Eduardo","family":"Sattui","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared W","family":"Magnani","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"},{"name":"Center for Research on Health Care, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,10,18]]},"reference":[{"key":"2025091513212033000_10.2.e000966.1","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211073001","article-title":"Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge","volume":"14","author":"Dima","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2025091513212033000_10.2.e000966.2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215089"},{"key":"2025091513212033000_10.2.e000966.3","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.067835"},{"key":"2025091513212033000_10.2.e000966.4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/0961203317717631","article-title":"Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease","volume":"27","author":"Iudici","year":"2018","journal-title":"Lupus"},{"key":"2025091513212033000_10.2.e000966.5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/acr.22837","article-title":"Hydroxychloroquine serum concentrations and flares of systemic lupus erythematosus: a longitudinal cohort analysis","volume":"68","author":"Mok","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025091513212033000_10.2.e000966.6","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/acr.23721","article-title":"Area-level predictors of medication nonadherence among US medicaid beneficiaries with lupus: a multilevel study","volume":"71","author":"Feldman","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025091513212033000_10.2.e000966.7","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180946"},{"key":"2025091513212033000_10.2.e000966.8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.rdc.2020.09.004","article-title":"Disparities in lupus and lupus nephritis care and outcomes among US medicaid beneficiaries","volume":"47","author":"Pryor","year":"2021","journal-title":"Rheum Dis Clin North Am"},{"key":"2025091513212033000_10.2.e000966.9","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/acr.24591","article-title":"Barriers to taking medications for systemic lupus erythematosus: a qualitative study of racial minority patients, lupus providers, and clinic staff","volume":"74","author":"Sun","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025091513212033000_10.2.e000966.10","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k3532","article-title":"The reporting of studies conducted using observational routinely-collected health data (RECORD) statement for Pharmacoepidemiology (RECORD-PE)","volume":"363","author":"Langan","year":"2018","journal-title":"BMJ"},{"key":"2025091513212033000_10.2.e000966.11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/09612033221093502","article-title":"COVID-19 in patients with systemic lupus erythematosus: a systematic review","volume":"31","author":"Fu","year":"2022","journal-title":"Lupus"},{"key":"2025091513212033000_10.2.e000966.12","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem233"},{"key":"2025091513212033000_10.2.e000966.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12962-015-0034-z","article-title":"The prevalence and burden of systemic lupus erythematosus in a medicare population: retrospective analysis of medicare claims","volume":"13","author":"Garris","year":"2015","journal-title":"Cost Eff Resour Alloc"},{"key":"2025091513212033000_10.2.e000966.14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s40744-023-00532-6","article-title":"Clinical and economic burden of systemic lupus erythematosus in the years preceding end-stage kidney disease diagnosis: a retrospective observational study","volume":"10","author":"Huang","year":"2023","journal-title":"Rheumatol Ther"},{"key":"2025091513212033000_10.2.e000966.15","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/03007995.2017.1321534","article-title":"Different approaches to the assessment of adherence and persistence with cardiovascular-disease preventive medications","volume":"33","author":"Malo","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"2025091513212033000_10.2.e000966.16","unstructured":"Pharmacy Quality Alliance (PQA) . PQA measure overview. 2019. Available: https:\/\/www.pqaalliance.org\/adherence-measures [Accessed 25 Jan 2021]."},{"key":"2025091513212033000_10.2.e000966.17","doi-asserted-by":"crossref","DOI":"10.1186\/s40545-021-00385-w","article-title":"Estimating proportion of days covered (PDC) using real-world online medicine suppliers' datasets","volume":"14","author":"Prieto-Merino","year":"2021","journal-title":"J Pharm Policy Pract"},{"key":"2025091513212033000_10.2.e000966.18","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e31829b1d2a"},{"key":"2025091513212033000_10.2.e000966.19","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/ajhp\/zxab392","article-title":"Proportion of days covered as a measure of medication adherence","volume":"79","author":"Loucks","year":"2022","journal-title":"Am J Health Syst Pharm"},{"key":"2025091513212033000_10.2.e000966.20","unstructured":"Pharmacy Quality Alliance . PQA\u2019s specialty core measures set. 2021. Available: https:\/\/www.pqaalliance.org\/assets\/Measures\/PQA_Specialty_Measure_Core_Set.pdf [Accessed 16 May 2020]."},{"key":"2025091513212033000_10.2.e000966.21","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903126833"},{"key":"2025091513212033000_10.2.e000966.22","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199801000-00004"},{"key":"2025091513212033000_10.2.e000966.23","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000182534.19832.83"},{"key":"2025091513212033000_10.2.e000966.24","unstructured":"Agency for Healthcare Research and Quality . Elixhauser comorbidity software refined for ICD-10-CM healthcare cost and utilization project (HCUP). Rockville, MD, 2022. Available: www.hcup-us.ahrq.gov\/toolssoftware\/comorbidityicd10\/comorbidity_icd10.jsp"},{"key":"2025091513212033000_10.2.e000966.25","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/art.39079","article-title":"Coverage for high-cost specialty drugs for rheumatoid arthritis in Medicare part D","volume":"67","author":"Yazdany","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2025091513212033000_10.2.e000966.26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3969","article-title":"Assessment of expected out-of-pocket spending for rheumatoid arthritis Biologics among patients enrolled in medicare part D, 2010-2019","volume":"3","author":"Erath","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025091513212033000_10.2.e000966.27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.semarthrit.2017.12.010","article-title":"Do out-of-pocket costs affect medication adherence in adults with rheumatoid arthritis? A systematic review","volume":"48","author":"Heidari","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2025091513212033000_10.2.e000966.28","doi-asserted-by":"publisher","DOI":"10.1002\/art.24114"},{"key":"2025091513212033000_10.2.e000966.29","first-page":"122","article-title":"Impact of out-of-pocket costs on prescription fills among new Initiators of biologic therapies for rheumatoid arthritis","volume":"22","author":"Hopson","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"key":"2025091513212033000_10.2.e000966.30","first-page":"45","article-title":"How patient cost-sharing trends affect adherence and outcomes: a literature review","volume":"37","author":"Eaddy","year":"2012","journal-title":"P T"},{"key":"2025091513212033000_10.2.e000966.31","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14075"},{"key":"2025091513212033000_10.2.e000966.32","doi-asserted-by":"publisher","DOI":"10.1177\/1060028016653609"},{"key":"2025091513212033000_10.2.e000966.33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.37765\/ajmc.2021.88664","article-title":"Association of co-pay elimination with medication adherence and total cost","volume":"27","author":"Cong","year":"2021","journal-title":"Am J Manag Care"},{"key":"2025091513212033000_10.2.e000966.34","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/acr.24397","article-title":"Access and cost-related Nonadherence to prescription medications among lupus patients and controls: the Michigan lupus epidemiology and surveillance program","volume":"73","author":"Minhas","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025091513212033000_10.2.e000966.35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.medcli.2017.05.035","article-title":"Adherence to treatment in patients with systemic lupus erythematosus","volume":"150","author":"Prados-Moreno","year":"2018","journal-title":"Med Clin (Barc)"},{"key":"2025091513212033000_10.2.e000966.36","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/acr.23792","article-title":"Azathioprine and mycophenolate mofetil adherence patterns and predictors among Medicaid beneficiaries with systemic lupus erythematosus","volume":"71","author":"Feldman","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025091513212033000_10.2.e000966.37","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keac133.109","article-title":"Adherence with mycophenolate mofetil in connective tissue disorders","volume":"61","author":"Chauhan","year":"2022","journal-title":"Rheumatology"},{"key":"2025091513212033000_10.2.e000966.38","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/acr.22636","article-title":"Medication Nonadherence is associated with increased subsequent acute care utilization among Medicaid beneficiaries with systemic lupus erythematosus","volume":"67","author":"Feldman","year":"2015","journal-title":"Arthritis Care & Research"},{"key":"2025091513212033000_10.2.e000966.39","doi-asserted-by":"publisher","DOI":"10.1002\/art.24236"},{"key":"2025091513212033000_10.2.e000966.40","doi-asserted-by":"crossref","first-page":"152042","DOI":"10.1016\/j.semarthrit.2022.152042","article-title":"Hydroxychloroquine and immunosuppressant adherence patterns and their association with subsequent hospitalization rates among children with systemic lupus erythematosus","volume":"56","author":"Chang","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"2025091513212033000_10.2.e000966.41","doi-asserted-by":"crossref","unstructured":"Aguirre A , DeQuattro K , Shiboski S , et al . Medication cost concerns and disparities in patient-reported outcomes among a multiethnic cohort of patients with lupus. J Rheumatol 2023:jrheum.2023-0060. doi:10.3899\/jrheum.2023-0060","DOI":"10.3899\/jrheum.2023-0060"},{"key":"2025091513212033000_10.2.e000966.42","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/acr.24550","article-title":"Impact of Antimalarial adherence on mortality among patients with newly diagnosed systemic lupus erythematosus: a population-based cohort study","volume":"74","author":"Hoque","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025091513212033000_10.2.e000966.43","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10050998","article-title":"High comorbidity burden in patients with SLE: data from the community-based lupus Registry of Crete","volume":"10","author":"Gergianaki","year":"2021","journal-title":"J Clin Med"},{"key":"2025091513212033000_10.2.e000966.44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cger.2017.01.007","article-title":"Polypharmacy reduction strategies: tips on incorporating American Geriatrics Society beers and screening tool of older people's prescriptions criteria","volume":"33","author":"Levy","year":"2017","journal-title":"Clin Geriatr Med"},{"key":"2025091513212033000_10.2.e000966.45","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.18.2799"},{"key":"2025091513212033000_10.2.e000966.46","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.33188","article-title":"Accuracy of physician estimates of out-of-pocket costs for medication filling","volume":"4","author":"Sloan","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2025091513212033000_10.2.e000966.47","doi-asserted-by":"publisher","DOI":"10.1002\/art.20819"},{"key":"2025091513212033000_10.2.e000966.48","doi-asserted-by":"publisher","DOI":"10.1002\/art.24063"},{"key":"2025091513212033000_10.2.e000966.49","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.191187"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2023-000966","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T20:21:30Z","timestamp":1757967690000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2023-000966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,10,18]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/lupus-2023-000966"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2023-000966","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}